Taiwan-based HMD Biomedical received a warning letter for inadequate procedures for device design validation, process control, and control of environmental conditions.

An inspection of the company’s facility in March 2016 revealed a failure to establish and maintain procedures for validating device design. In one instance, a software validation test report contained six columns for evaluation of six meters, but only two meters were marked with “OK” test results.